Plasma changes in breast cancer patients during endocrine therapy--lipid measurements and nuclear magnetic resonance (NMR) spectroscopy (Q70930526)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Plasma changes in breast cancer patients during endocrine therapy--lipid measurements and nuclear magnetic resonance (NMR) spectroscopy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

4

P E Lønning

1 reference

14 October 2019

T Engan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

J Krane

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

D C Johannessen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

S Kvinnsland

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

14 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

287-297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00713400

14 October 2019

exact match

0 references

cites work

1H and 13C nuclear magnetic resonance studies of plasma from patients with primary intracranial neoplasms

1 reference

12 December 2020

Changes in serum lipids and lipoproteins in cancer patients during chemotherapy

1 reference

12 December 2020

Elevated lipoprotein(a) levels in patients with acute myeloblastic leukaemia decrease after successful chemotherapeutic treatment

1 reference

12 December 2020

The prevention of breast cancer

1 reference

12 December 2020

Characterization of plasma lipids in patients with malignant disease by 13C nuclear magnetic resonance spectroscopy and gas liquid chromatography

1 reference

12 December 2020

An NMR blood test for cancer: a critical assessment

1 reference

12 December 2020

Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer

1 reference

12 December 2020

C-13 NMR spectroscopy of plasma reduces interference of hypertriglyceridemia in the H-1 NMR detection of malignancy. Application in patients with breast lesions

1 reference

12 December 2020

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

1 reference

12 December 2020

Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy

1 reference

12 December 2020

The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study

1 reference

12 December 2020

Proton magnetic resonance spectroscopy of fractionated plasma lipoproteins and reconstituted plasma from healthy subjects and patients with cancer

1 reference

12 December 2020

Relationships between the proton nuclear magnetic resonance properties of plasma lipoproteins and cancer

1 reference

12 December 2020

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels

1 reference

12 December 2020

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme

1 reference

12 December 2020

Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma: significant variations with extent of breast cancer, duration of pregnancy and aging

1 reference

12 December 2020

Oestrogens and atherosclerotic vascular disease--lipid factors

1 reference

12 December 2020

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

12 December 2020

Proton magnetic resonance spectroscopy of plasma from patients with dyslipoproteinemia: identification of factors governing methyl and methylene proton line widths.

1 reference

12 December 2020

Prospects for the Primary Prevention of Breast Cancer

1 reference

12 December 2020

Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer

1 reference

12 December 2020

Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen

1 reference

12 December 2020

Early changes in the 1H-NMR plasma spectrum in patients following breast surgery

1 reference

12 December 2020

Tamoxifen, serum lipoproteins and cardiovascular risk

1 reference

12 December 2020

Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00713400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573711%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference